Ruti Aga's Six-Year Ban: The Prescription No Clinic Ever Issued

The stamp on that prescription belonged to a clinic that does not exist. The hand that wrote it belonged to a family member of the Ethiopian marathoner Ruti Aga, a person with no medical registration anywhere on file. The paper itself, according to the Athletics Integrity Unit, came from an old prescription pad kept from a former workplace. The AIU contacted that workplace. The answer came back that no such pad had ever been issued. Three separate verifications, three identical answers.

The document surfaced in March, after Aga won a half marathon in China and a sample collected there returned methylprednisolone. On Thursday the AIU announced a six-year ban, effective from 10 September, backdated to the provisional suspension. She is 32. When the ban lifts she will be 38. In women's marathon, a return at that age is open on paper and closed in practice.

Her record is the record of the near-champion. She won the Tokyo Marathon in 2026, a World Marathon Major title, and owns three runner-up finishes at Majors. Her personal best is commonly given as roughly 2:18:34 from Berlin 2026, second place — though the AIU statement does not contain the mark, so I am treating it as pending verification. The Chinese half marathon's time, splits and field quality are recorded nowhere in the material. All the source establishes is that she won it and was tested afterwards. A race with an AIU sample collector present is a World Athletics Label-tier elite race; that is inference, not document.

The knee is where the case begins. Her defence was that methylprednisolone was administered for a knee injury. Intra-articular and peri-articular injections for knee synovitis are standard sports-medicine practice in distance running, and that plausibility is exactly why the forgery became decisive: a genuine treatment would have been defended with genuine records. In the medical room the scoreboard disappears and the body speaks. Here the body spoke first, and the paperwork buried it.

This is where almost all of the reporting went sideways. Methylprednisolone is not an anabolic steroid. It is a glucocorticoid — WADA Prohibited List class S9 — and it is prohibited in-competition only, by injection, oral or rectal route. A therapeutic knee injection given out of competition is entirely legal. It becomes a violation only if residues are present inside the competition testing window, which for a road race opens at 23:59 the day before the gun. The entire case therefore turned on route of administration and timing, not on steroid use. A genuine prescription, a correctly observed washout, and records filed with the AIU could have reduced the presence charge to nothing. By manufacturing the prescription, Aga destroyed the only defence that could have worked.

The sanction arithmetic is standard. Two years for the presence violation plus four years for tampering equals six. A two-year presence sanction is the ordinary outcome for a Specified Substance where intent is not proven; four years is the Code's standard tampering penalty, and it rests on statements made in an investigative interview rather than on the forged paper alone. Read together, the panel did not find intent on the substance but held her fully culpable on the fabrication. Backdating to 10 September is procedural, not lenient — provisional suspension time simply counts against the ban.

The harder question is why an athlete of her standing went to a relative with no medical registration for a knee injection. I keep a file on every knee, and the file always starts with a question. Here the question is not what she took but who her team physician was. The answer is nobody: no credentialed travelling doctor, no therapeutic use exemption infrastructure. For a 2:18 marathoner that is a structural fact, not a personal lapse. These athletes live on appearance fees rather than employment contracts; where there is no payslip, there is also nobody whose job it is to own the medical bill.

I came to this beat for the economics; I stayed for the medicals. Sitting near the fourth official at the Kolkata Under-17 World Cup in 2026, what struck me was that a major event has a protocol and a week's earnings does not. China's label races are precisely that earnings strip for East African marathoners — the lucrative, low-risk tier between Majors. That same tier is now the AIU's highest-yield testing ground, and the appearance-fee economy is colliding with the testing economy inside the same races.

The counter-intuitive turn is this: in Ethiopian women's marathon, a 2:18 runner is not automatically selectable. The national depth is so extreme that the removal of a 32-year-old with no global championship medals changes nothing in selection calculus. What is actually shifting is the enforcement frontier — from detection to document verification. Aga belongs to a recognizable family of East African road cases where an initial substance violation is compounded by a fabricated explanation, and the same informal medical networks serve entire training clusters. More such files are plausible. Note also that criminal exposure over document forgery sits outside AIU jurisdiction; no national referral is mentioned.

The stake looks disproportionate: the original charge involved a substance with no proven endurance benefit, and the outcome is six years. That will be cited as evidence of AIU rigour and as evidence of over-enforcement against African road runners. Both readings come from the same statement, and the truth sits between them — the punishment was for the paper, not the drug.

The next file will not be hers. It will belong to whoever signs the return-to-play sheet confirming a knee is race-ready, and to whether any league, federation or label race keeps that signature on record. The knee knew first, but the knee never held the prescription pad — and that gap is what ended a career.